Immune Checkpoint Therapy in Melanoma

    loading  Checking for direct PDF access through Ovid

Abstract

Checkpoint-blocking antibodies have transformed cancer therapy, and the treatment of patients with metastatic melanoma has led the revolution. Herein, we review the current clinical data supporting the use of checkpoint-blocking antibodies in the treatment of melanoma and highlight outstanding clinical questions and unmet clinical needs.

Related Topics

    loading  Loading Related Articles